Aesthetic Connect Public Company LimitedSET: TRP🇹🇭 TH

MD&A · 2024

Overview of Operations

Overview of Operations

The company operates in the field of cosmetic facial surgery services under the name 'Teeraporn Clinic'. The medical team consists of specialized experts with extensive experience and wide recognition in the industry. The company offers various services including facelift surgery, eye surgery, rhinoplasty, and skincare.

2022 - 2024 The company had revenue from services for the year 853.64 million Baht, 707.83 million Baht and 533.65 million Baht, or decreased by 17.08% and declined by 24.61% respectively and the company had net profit for the year ended 270.27 million Baht, 192.56 million Baht and 139.37 million Baht. Representing for 31.64%, 27.01% and 25.12% of the total revenue.

The company's operating results in 2022 - 2024 will decrease, expected to be due to the economic recession. Including being a service business group that is becoming popular and there are many business competitors with many brands As a result, there is very high competition in this business sector. This gives service users many opportunities and options in using this service.

In 2022, the Company purchased land with a total value of 306.26 million baht. To be used for the construction of a new hospital. As of December 31, 2022, the Company's outstanding long-term loans amounted to 109.54 million Baht. As of October 18, 2023, the Company has repaid long-term loans from financial institutions in full ahead of schedule in the amount of 96.85 million Baht without paying any fees and all collateral has been redeemed.

In 2023, the Company has transformed from a limited company to a public company limited. It was approved to change its share par value from Baht 10 per share to Baht 0.50 per share resulting change in numbers of common shares from 13 million shares to 260 million shares.

In addition the Company to increase its authorized share capital from Baht 130 million to Baht 175 million to support the stock initial public offering in Market for Alternative Investment (MAI). And the dividend has been paid to shareholders from the Company's retained earnings as of 31 December 2022 at the rate of Baht 1.027 per share, totaling Baht 267.02 million. The dividend is due to be paid by March 31, 2023, and the Company pays dividends to shareholders using the Company's cash flow.

At the Board of Directors Meeting held on November 9, 2023, it was approved to pay interim dividend from the net profit for 9 months ended September 30, 2023 at 0.10 per share of 350 million shares totaling Baht 35 million on December 8, 2023.

At the Board of Directors’ meeting held on February 22,2024 it was approved to propose at the Annual General Meeting of the shareholders to pay dividend from retained earnings at Baht 0.30 per share of 350 million shares totaling 105 million Baht.

In 2024 At the Board of Directors' meeting held on February 21,2025 passed resolutions Approved to propose at the Annual General Meeting of the shareholders to pay dividend form the net profit for the year at Baht 0.20 per share of 350 million shares totaling Baht 70 million. and approved the buy back shares scheme for the Company’s financial management at the limited amount not more than Baht 120 million for not more than 14 million shares which are accounting for 4% of its total paid-up shares (par value Baht 0.50 per share). The buy back period was set to be from March 3, 2025 to September 2, 2025 in which the Board of Directors shall determine the selling method and period of the treasury shares later.

Operating Results & Financial Condition

Operating Results & Profitability

Analysis of operating results and financial position Based on information from the Company's financial statements. For the year ended December 31, 2022 – 2023 and for the year ended December 31, 2024, the revenue structure details are as follows:

Revenue from services

In 2022-2023 and for the year ended December 31, 2024, the Company's revenue from services was 853.64 million Baht 707.83 Million Baht and 533.65 Million Baht The growth rate was 99.61 percent decreased (17.08 percent) and decreased (24.61 percent) compared to the same period, respectively.


Revenue from surgery-related services

In 2022-2023 and for the year ended December 31, 2024, the Company's revenue from surgical procedures was 796.07 million baht 657.79 million baht and 487.21 million baht, Percent of revenue services was 93.26 percent 92.93 percent and 91.30 percent, respectively. The main revenue comes from Face-Lock Facelift, Eye-Lock Eyelid Surgery Rhinoplasty Surgery and Other Surgery.

In 2022, the company generated revenue of 796.07 million baht from surgery-related procedures, accounting for 93.26% of total service revenue. This included 541.15 million baht from facelift surgeries, 174.55 million baht from eye surgeries, 44.57 million baht from nose surgeries, and 35.80 million baht from other surgical procedures. The revenue from surgery-related procedures in 2022 increased by 399.61 million baht, representing a growth rate of 100.79% compared to 2021.

In 2023, the company generated revenue of 657.79 million baht from surgery-related procedures, accounting for 92.93% of total service revenue. This included 436.95 million baht from facelift surgeries, 133.03 million baht from eye surgeries, 38.96 million baht from nose surgeries, and 48.85 million baht from other surgical procedures. The revenue from surgery-related procedures in 2023 decreased by 138.28 million baht, representing a decline of 17.37% compared to 2022.

For the year ended December 31, 2024, the company generated revenue of 487.21 million baht from surgery-related procedures, accounting for 91.30% of total service revenue. This included 292.98 million baht from facelift surgeries, 106.00 million baht from eye surgeries, 28.52 million baht from nose surgeries, and 59.71 million baht from other surgical procedures. Revenue from surgery-related procedures decreased by 170.58 million baht, representing a decline of 25.93% compared to the same period in 2023.

The company's performance declined from 2022 to 2024, likely due to the economic recession and the increasing competition in the beauty service industry. With numerous brands entering the market, competition has intensified, providing customers with more choices and alternatives. The revenue decline was primarily attributed to the following factors: 1) Facelift surgery revenue decreased by 143.97 million baht, a 32.95% decline compared to the same period in 2023. This was due to a drop in customers opting for two-stage facelift procedures, which are relatively high-cost services. 2) Eye surgery revenue declined by 27.03 million baht, or 20.32% mainly due to a reduction in customers seeking eyelid surgery for droopy eyelid correction. 3) Nose surgery revenue dropped by 10.44 million baht, a 26.80% decrease, as the number of customers undergoing all types of nose surgery declined. Despite these declines, revenue from other surgical procedures increased by 10.87 million baht, reflecting a 22.24% growth compared to the same period in 2023. This growth was driven by an increase in customers seeking fat grafting, liposuction, hair transplantation, chin liposuction, and buccal fat removal services.


The revenue from Intravenous Anesthesia Services

Certain surgical procedures may require anesthesia to ensure patient comfort, such as facelift surgery and double eyelid surgery. Additionally, anesthesia may be necessary for other surgical cases, particularly for elderly patients or those with underlying health conditions. The anesthesia service is provided through intravenous (IV) sedation, where an appropriate amount of anesthetic is administered before the procedure. This allows patients to feel relaxed and comfortably drowsy while still being able to breathe on their own. IV sedation is considered safer than general anesthesia as it has fewer side effects.

From 2022-2023 and for the year ended December 31, 2024,, the company generated revenue from anesthesia services of 36.62 million baht, 30.53 million baht, and 23.53 million baht, respectively. The proportion of anesthesia service revenue to total service revenue was 4.29%, 4.31%, and 4.41%, respectively.


Revenue from Non-Surgical Services

Non-surgical service revenue includes procedures such as dermal filler injections for wrinkle reduction and facial contouring, Botox injections for wrinkle reduction and facial shaping, and other skin-related treatments such as HIFU, Ultherapy, lab check-ups, and skin vitamin therapy. Some customers who use non-surgical services are those who have also undergone surgical procedures, seeking additional treatments to enhance or maintain their results.

From 2022-2023 and for the year ended December 31, 2024, the company generated revenue from non-surgical services (Skin Care) of 20.96 million baht, 19.51 million baht, and 22.92 million baht, respectively. The proportion of non-surgical service revenue to total service revenue was 2.46%, 2.76%, and 4.29%, respectively.

In 2023, revenue from non-surgical services decreased by 1.45 million baht, a 6.92% decline compared to 2022. This was mainly due to a drop in revenue from Botox injections and Babi Neo One fat-dissolving injections.

However, in 2024, non-surgical service revenue increased by 3.41 million baht, reflecting a 17.47% growth compared to 2023. This growth was driven by the company’s efforts to expand its customer base and successfully boost sales in the Skin Care segment.


Other Revenue

From 2022-2023 and for the year ended December 31, 2024, the company generated other revenue of 0.43 million baht, 5.20 million baht, and 21.09 million baht, respectively, accounting for 0.05%, 0.73%, and 3.80% of total revenue. This revenue primarily came from interest income on fixed deposits.


Cost of Services

From 2022-2023 and for the year ended December 31, 2024, the company’s cost of services amounted to 380.51 million baht, 319.45 million baht, and 252.44 million baht, respectively. The cost-to-service revenue ratio was 44.57%, 45.13%, and 47.30%, respectively. The main cost components included doctor fees, commissions, employee-related expenses, and costs of medications and medical supplies.

In 2022, the company’s cost of services amounted to 380.51 million baht, accounting for 44.58% of service revenue. This represented an increase of 172.80 million baht, or 83.19% growth compared to 2021. The main cost components were: Doctor fees: 329.49 million baht (38.60% of service revenue) Cost of medications, medical supplies, and other materials: 18.71 million baht (2.19% of service revenue) Employee-related expenses: 17.57 million baht (2.06% of service revenue) The increase in cost of services was primarily driven by: Higher doctor fees, which rose by 158.58 million baht (92.79% growth from 2021), aligning with the overall increase in service revenue. Higher costs of medications, medical supplies, and other materials, which increased by 8.43 million baht (82.07% growth), also following the upward trend in service revenue.

In 2023, the company's cost of services amounted to 319.45 million baht, accounting for 45.13% of service revenue, representing a decrease of 61.06 million baht compared to the same period in 2022. The main cost components were: Doctor fees: 267.65 million baht (37.81% of service revenue) Cost of medications, medical supplies, and other materials: 16.98 million baht (2.40% of service revenue) Employee-related expenses: 19.27 million baht (2.72% of service revenue) The decrease in cost of services was primarily due to a reduction in doctor fees, which declined in line with the decrease in service revenue.

For the year ended December 31, 2024, the company's cost of services amounted to 252.44 million baht, accounting for 47.30% of service revenue. This represents a decrease of 67.01 million baht, or 20.98%, compared to 2023. The main cost components were: Doctor fees: 199.27 million baht (78.94% of service revenue) Employee-related expenses: 20.27 million baht (8.03% of service revenue) Cost of medications, medical supplies, and other materials: 15.55 million baht (6.16% of service revenue) The decline in service costs was primarily due to the reduction in doctor fees and costs of medications and medical supplies, which decreased in line with the overall decline in service revenue.


Gross Profit and Gross Profit Margin

From 2022-2023 and for the year ended December 31, 2024, the company’s gross profit from services amounted to 473.12 million baht, 388.37 million baht, and 281.22 million baht, respectively. The gross profit margin was 55.42%, 54.87%, and 52.70%, respectively.

In 2022, the company’s gross profit from services amounted to 473.13 million baht, representing a gross profit margin of 55.42%. This was an increase of 253.20 million baht, or 115.13% growth, compared to 2021. The increase aligned with the growth in service revenue, which rose by 426.00 million baht, or 99.61%, from 2021. This revenue growth was driven by the easing of the COVID-19 pandemic, as more people received their third and fourth vaccine doses. Additionally, during the pandemic, the company invested heavily in online marketing, leading to greater brand awareness and customer engagement. At the same time, the company’s doctors and staff continuously improved service quality at all levels. Meanwhile, cost of services increased by 172.80 million baht, or 83.19%, compared to 2021. However, the cost increase was lower than the revenue growth rate, as the company effectively managed expenses related to medications, medical supplies, and employee-related costs.

In 2023, the company’s gross profit from services amounted to 388.38 million baht, representing a gross profit margin of 54.87%. This reflected a 17.91% decline compared to the same period in 2022, in line with the decrease in service revenue. The decline was attributed to changing consumer behavior. From 2020 to 2022, international travel restrictions due to COVID-19 led many individuals to opt for cosmetic procedures during long holidays instead. However, by 2023, as travel returned to normal, some people prioritized tourism over cosmetic surgery, resulting in fewer customers. Additionally, the company’s cost of services decreased by 61.06 million baht, or 16.05%, compared to 2022, aligning with the revenue decline. However, employee-related expenses increased, which contributed to a slight reduction in the gross profit margin compared to the previous year.

For the year ended December 31, 2024, the company’s gross profit from services amounted to 281.21 million baht, with a gross profit margin of 52.70%. This represented a 27.59% decline, in line with the decrease in service revenue, which dropped by 174.18 million baht, or 24.61%.


Selling and Administrative Expenses

From 2022-2023 and for the year ended December 31, 2024, the company’s selling and administrative expenses amounted to 131.24 million baht, 148.12 million baht, and 132.68 million baht, respectively. These expenses accounted for 15.37%, 20.93%, and 24.86% of service revenue for each year. The changes in selling and administrative expenses can be explained as follows:

Selling Expenses

The company's key selling expenses include: Promotional expenses Employee-related expenses Consulting fees and professional service fees The details of selling expenses for the years 2022–2024 are as follows:

In 2022, the company’s selling expenses amounted to 89.28 million baht, accounting for 10.46% of service revenue. This represented an increase of 32.44 million baht, or 57.06% growth, compared to 2021. The main factors contributing to this increase were: Promotional expenses increased by 18.65 million baht (47.16% growth) due to the company’s continuous investment in marketing activities. Employee-related expenses in the marketing department rose by 14.44 million baht (119.85% growth) due to an increase in senior marketing staff and higher employee commissions, which aligned with the growth in service revenue.

In 2023, the company’s selling expenses amounted to 99.08 million baht, accounting for 13.99% of service revenue. This represented an increase of 9.80 million baht, or 10.98% growth, compared to 2022. The main factors contributing to this increase were: Higher promotional expenses of 26.74 million baht, driven by increased marketing efforts through both online and offline advertising channels. Employee-related expenses increased by 1.43 million baht. Commission expenses decreased by 14.57 million baht, aligning with the decline in service revenue. Other expenses decreased by 3.8 million baht.

For the year ended December 31, 2024, the company’s selling expenses amounted to 84.64 million baht, accounting for 15.86% of service revenue. This represented a decrease of 14.44 million baht, or a 14.57% decline, compared to 2023. The main reason for this decrease was the reduction in advertising, promotional expenses, and commissions, which declined in line with the decrease in service revenue. The company also focused on optimizing promotional expenses to maximize efficiency.


Administrative Expenses

Key Administrative Expenses The company's key administrative expenses include: Employee-related expenses Bank fees Depreciation expenses Other administrative expenses The details of administrative expenses for the years 2022–2024 are as follows:

In 2022, the company’s administrative expenses amounted to 41.97 million baht, accounting for 4.92% of service revenue. The key components included: Employee-related expenses: 16.89 million baht Bank fees: 9.01 million baht Depreciation expenses: 4.51 million baht The primary reason for the increase in administrative expenses was the higher employee expenses in the management department. In 2022, the company expanded its workforce and management team to support business growth and prepare for its initial public offering (IPO). Additionally, bank fees increased in line with revenue growth, as more customers opted to pay via credit cards, reflecting the rise in service revenue.

In 2023, the company’s administrative expenses amounted to 49.04 million baht, accounting for 6.93% of service revenue. This represented an increase of 7.07 million baht, or 16.85% growth, compared to 2022. The main factors contributing to this increase were: Expansion of the workforce and management team to support the company’s growth. Preparation expenses related to the company's initial public offering (IPO).

For the year ended December 31, 2024, the company’s administrative expenses amounted to 48.03 million baht, accounting for 9.00% of service revenue. This represented a decrease of 1.01 million baht, or a decline of 2.06%, compared to 2023. The reduction was mainly due to a decrease in bank fees, consulting fees, and professional service fees, which aligned with the overall decline in revenue. This was a result of the company’s efforts to control and reduce administrative expenses.

Financial costs

From 2022-2023 and for the year ended December 31, 2024, the company’s finance costs amounted to 2.79 million baht, 1.89 million baht, and 0.40 million baht, representing 0.33%, 0.27%, and 0.07% of service revenue, respectively. This decrease was due to the company's full repayment of a 118 million baht loan, which was used for the purchase of land to construct Teeraporn Hospital in Q4 2023. As a result, in 2024, the company’s remaining finance costs consisted solely of interest on lease liabilities.


Net profit and net profit margin

From 2022 to 2024, the company recorded a net profit of 270.27 million baht, 192.56 million baht, and 139.37 million baht, respectively, representing a net profit margin of 31.64%, 27.01%, and 25.12%, respectively.

In 2022, the company's net profit margin increased from 26.34% in 2021 to 31.64%. This was driven by higher revenue due to an increase in service users, as the public began receiving COVID-19 vaccinations and resumed normal activities. Additionally, the company's brand awareness improved through continuous advertising efforts. The company also achieved better cost management, with most cost increases stemming from physician fees and commissions, which were variable expenses linked to revenue. As a result, the company maintained a higher gross profit margin. Moreover, selling and administrative expenses increased, primarily due to advertising and promotional expenses, commissions, and administrative staff costs. However, the increase in selling and administrative expenses was proportionally lower than the revenue growth, allowing the company to achieve a higher net profit margin.

In 2023, the company's net profit margin decreased from 31.64% in 2022 to 27.01%. This decline was primarily due to a decrease in revenue, which was likely impacted by economic conditions and political uncertainties in the country. Additionally, as tourism returned to normal after the COVID-19 pandemic, some consumers opted for travel over cosmetic surgery. Furthermore, in 2023, the company experienced higher selling expenses due to increased marketing efforts across both online and offline channels, as well as a rise in administrative staff costs. These factors contributed to a lower net profit margin for the year.

For the year ended December 31, 2024, the company's net profit margin decreased from 27.01% in 2023 to 25.12%. This decline was primarily due to a drop in revenue, which resulted from the economic recession and the highly competitive nature of the service industry, as it continues to grow in popularity.


The analysis of the financial position statement

As of December 31, 2022 – December 31, 2024, the company’s total assets amounted to 802.81 million baht, 1,795.46 million baht, and 1,871.79 million baht, respectively. The company’s main assets include cash and cash equivalents, other current financial assets, land, leasehold improvements and equipment, investment properties, and right-of-use assets, with details as follows:

Cash and cash equivalents

As of December 31, 2022 – December 31, 2024, the company had cash and cash equivalents amounting to 354.43 million baht, 255.30 million baht, and 408.16 million baht, which represent 44.15%, 14.22%, and 21.81% of total assets, respectively.

As of December 31, 2022, the company’s cash increased by 25.16 million baht compared to 2021, representing an increase of 7.64%. This was due to an increase in profit before income tax from 2021, amounting to 198.23 million baht, and receiving funds from a long-term loan from a financial institution totaling 118.00 million baht. However, the company used the funds to purchase land for the construction of a new hospital, amounting to 306.26 million baht.

As of December 31, 2023, the company’s cash decreased by 99.13 million baht compared to December 31, 2022, representing a decrease of 27.97%. This was due to the company paying dividends amounting to 267.02 million baht in Q2/2023 and an interim dividend of 0.10 baht per share, totaling 35 million baht, in Q4/2023.

As of December 31, 2024, the company’s cash increased by 152.86 million baht compared to December 31, 2023, representing an increase of 59.88%. This was due to the company using funds from short-term investments in fixed deposits to prepare reserves for the payment of construction debts related to the hospital, resulting in a higher cash and cash equivalents balance.

The changes in cash and cash equivalents are primarily due to the impact of the increase or decrease in the company’s net cash from operating activities, investing activities, and financing activities.


Net property, Lease building improvement and equipment

As of December 31, 2022, the company’s land, leasehold improvements, and equipment increased by 309.30 million baht compared to 2021, due to the purchase of land covering an area of 2-2-83 rai located on Somdet Phra Chao Taksin Road, Samre Sub-district, Thonburi District, Bangkok, valued at 306.26 million baht.The purpose of constructing the new hospital is to expand the capacity to accommodate the increasing number of service users.

As of December 31, 2023, the company’s land, leasehold improvements, and equipment increased by 70.88 million baht compared to 2022, due to vehicles and assets under construction for the new hospital, which is currently being built.

As of December 31, 2024, the company’s land, leasehold improvements, and equipment increased by 340.13 million baht compared to 2023, due to assets under construction for the new hospital, which is currently being built.


Investment properties

As of December 31, 2022 – December 31, 2024, the company had investment properties amounting to 90.02 million baht, 89.58 million baht, and 89.14 million baht, which represented 11.21%, 4.99%, and 4.76% of total assets, respectively. The properties consisted of land with buildings on an area of 0-3-85 rai located on Charoen Krung Road, valued at 90.46 million baht. When the property was acquired, the company’s management intended to demolish the building and construct a new hospital. However, due to increased revenue, the Extraordinary General Meeting of Shareholders No. 3/2021 on December 3, 2021, resolved to sell the land and building because the space was insufficient. The company then purchased a new piece of land that is larger and more suitable for the hospital’s needs.


Net Right-Use Assets

As of December 31, 2022 – December 31, 2024, the company had right-of-use assets (net) amounting to 24.91 million baht, 13.25 million baht, and 3.63 million baht, which represented 3.10%, 0.74%, and 0.19% of total assets, respectively. The right-of-use assets consist of office buildings and vehicles, with lease terms of approximately 5 to 6 years, recognized in accordance with Thai Financial Reporting Standard No. 16 (TFRS 16).


Liabilities

As of December 31, 2022 – December 31, 2024, the company had total liabilities amounting to 233.48 million baht, 108.61 million baht, and 150.54 million baht, which represented 29.08%, 6.05%, and 8.04% of total liabilities and shareholders' equity, respectively. The company’s main liabilities include trade payables, other payables, lease liabilities, and current liabilities arising from contracts, with details as follows:


Trade payables and other payables

As of December 31, 2022, the company had trade payables and other payables amounting to 45.60 million baht, an increase of 4.47 million baht compared to 2021. The increase was mainly due to accrued advertising expenses.

As of December 31, 2023, the company had trade payables and other payables amounting to 49.98 million baht, an increase of 4.38 million baht compared to 2022. The increase was mainly due to accrued advertising expenses.

As of December 31, 2024, the company had trade payables and other payables amounting to 83.34 million baht, an increase of 33.36 million baht compared to 2022. The increase was mainly due to construction payables for the hospital.


Lease liabilities

Lease liabilities consist of liabilities under lease agreements for office buildings, vehicles, and office equipment, with lease terms of approximately 4 to 6 years, recognized in accordance with Thai Financial Reporting Standard No. 16 (TFRS 16).

As of December 31, 2021 – December 31, 2024, the company had lease liabilities amounting to 23.24 million baht, 13.66 million baht, and 3.86 million baht, which represented 2.90%, 0.76%, and 0.21% of total liabilities and shareholders' equity, respectively. These lease liabilities were divided into current lease liabilities due within one year, amounting to 9.76 million baht, 9.91 million baht, and 3.65 million baht, and non-current lease liabilities due beyond one year, amounting to 13.48 million baht, 3.75 million baht, and 0.21 million baht, respectively. In 2024, the company’s lease liabilities decreased due to regular lease payments and a reduction compared to 2023.There is vehicle that have reached the end of their lease term.

Current liabilities arising from contracts

Current liabilities arising from contracts consist of advance service fees and unrecognized service revenue. As of December 31, 2022 – December 31, 2024, the company had current liabilities arising from contracts amounting to 18.66 million baht, 18.43 million baht, and 20.76 million baht, which represented 2.32%, 1.03%, and 1.11% of total liabilities and shareholders' equity, respectively. The increase in current liabilities arising from contracts was due to the rise in advance service fees received.


Shareholders' equity

As of December 31, 2022 – December 31, 2024, the company’s shareholders' equity amounted to 569.33 million baht, 1,686.85 million baht, and 1,721.25 million baht, respectively, representing 70.92%, 93.95%, and 91.96% of total liabilities and shareholders' equity in each period. Shareholders' equity consists of the issued and fully paid-up share capital, share premium, and retained earnings, including legal reserve and unappropriated retained earnings.

In 2022, the company’s shareholders' equity amounted to 569.33 million baht, an increase of 210.44 million baht, or a 58.64% increase from 2021, due to the growth in retained earnings. During the year 2022, the company paid dividends as follows:

On April 30, 2022, the Annual General Meeting of Shareholders approved the payment of a 2021 annual dividend of 59.80 million baht, equivalent to 4.60 baht per share, and also set aside a legal reserve of 3.25 million baht.

In 2023, the company’s shareholders' equity amounted to 1,686.85 million baht, an increase of 1,117.53 million baht, or a 196.29% increase from 2022, due to the company offering 90 million shares to the public for the first time through an Initial Public Offering (IPO) between October 10-12, 2023. The shares had a par value of 0.50 baht per share and were offered at 14 baht per share, raising a total of 1,260 million baht.

Subsequently, on October 16, 2023, the company received full payment for the shares, and the Market for Alternative Investment (MAI) registered 350 million common shares with a par value of 0.50 baht per share. These shares were officially listed, and trading commenced on October 24, 2023, under the services sector, with the trading symbol "TRP."

As of December 31, 2024, the company’s shareholders' equity amounted to 1,721.25 million baht, an increase of 34.40 million baht, or a 2.04% increase from 2023, due to the growth in retained earnings.


Cash flow analysis

As of December 31, 2022 – December 31, 2024, the company had cash and cash equivalents amounting to 354.43 million baht, 255.30 million baht, and 408.16 million baht, which represented 44.15%, 14.22%, and 21.81% of total assets, respectively.

In 2022, the company had cash and cash equivalents at the beginning of the year amounting to 329.27 million baht and generated cash flow from operating activities of 301.66 million baht. This resulted from profit before tax of 339.53 million baht, adjusted by non-cash items of 17.70 million baht, changes in operating assets and liabilities of 3.40 million baht, and income tax and interest payments of 58.97 million baht. The changes in operating assets and liabilities were mainly impacted by: 1) an increase in trade and other payables by 4.18 million baht, 2) an increase in current liabilities arising from contracts by 3.06 million baht, and 3) an increase in trade and other receivables by 2.94 million baht. The company used 314.84 million baht in investing activities, mostly for purchasing land to build a new hospital to accommodate the growing number of service users. Additionally, the company received cash from financing activities amounting to 38.34 million baht, including cash received from a loan of 118.00 million baht from a financial institution to purchase land for the new hospital. The company repaid part of the loan amounting to 8.46 million baht. The company also paid dividends to shareholders amounting to 59.80 million baht and paid lease liabilities of 8.37 million baht. As a result of cash inflows and outflows from all the activities mentioned above, the company had a net increase in cash flow of 25.16 million baht in 2022, which led to an increase in cash and cash equivalents at the end of the year to 354.43 million baht.

In 2023, the company had cash and cash equivalents at the beginning of the year amounting to 354.43 million baht and generated cash flow from operating activities of 266.19 million baht. This was driven by a profit before tax of 243.55 million baht, adjusted by non-cash items amounting to 13.61 million baht, changes in operating assets and liabilities of 9.03 million baht, and income tax and interest payments of 59.34 million baht. The changes in operating assets and liabilities were mainly impacted by: 1) an increase in trade and other payables by 2.31 million baht, 2) an increase in trade and other receivables by 1.41 million baht, 3) an increase in other current liabilities by 2.82 million baht, and 4) an increase in other non-current liabilities by 2.45 million baht. The company used 1,101.71 million baht in investing activities, which included investments in 6-month fixed deposits and expenditures for the construction of the new hospital. Additionally, the company used 795.74 million baht in financing activities, which included cash received from an Initial Public Offering (IPO) of 90 million shares with a par value of 0.50 baht per share, offered at 14 baht per share, raising a total of 1,260 million baht. The company also paid dividends to shareholders amounting to 302.01 million baht and repaid long-term loans from a financial institution amounting to 109.54 million baht. As a result of the cash flows from all the activities mentioned above, the company had a net decrease in cash flow of 99.13 million baht for the year, leading to a reduction in cash and cash equivalents at the end of the year to 255.30 million baht.

In 2024, the company had cash and cash equivalents at the beginning of the year amounting to 255.30 million baht and generated cash flow from operating activities of 153.11 million baht. This was driven by a profit before tax of 169.23 million baht, adjusted by non-cash items of 3.10 million baht, changes in operating assets and liabilities of 13.02 million baht, and income tax and interest payments of 33.06 million baht. The changes in operating assets and liabilities were mainly impacted by: 1) a decrease in trade and other payables by 21.33 million baht, 2) an increase in contract liabilities by 2.32 million baht, and 3) an increase in trade and other receivables by 8.88 million baht. Additionally, the company generated cash in investing activities of 148.36 million baht by investing short-term deposits from the funds raised through the IPO to reserve for payment to construction creditors for the hospital construction and also earned interest income from those fixed deposits. In financing activities, the company used cash amounting to 115.54 million baht, which included payments for lease liabilities along with interest payments of 10.57 million baht and dividend payments to shareholders totaling 104.97 million baht. As a result of the cash flows from all the activities mentioned above, the company had a net increase in cash flow of 152.86 million baht for the year, leading to an increase in cash and cash equivalents at the end of the year to 408.16 million baht.


Analysis of Key Financial Ratios

Liquidity Ratios

As of December 31, 2022 – December 31, 2024, the company had liquidity ratios of 2.91 times, 13.08, and 7.79, respectively. On December 31, 2022, the company’s liquidity ratio decreased from 2021 due to an increase in current liabilities, primarily from borrowing funds from a financial institution to purchase land for the construction of a new hospital.

In 2023, the company’s liquidity ratio increased from 2022 due to an increase in registered capital by 45 million THB, from the original registered capital of 130 million THB to 175 million THB. Between October 10-12, 2023, the company offered newly issued common shares to the public for the first time (Initial Public Offering) on the Market for Alternative Investment (MAI). On October 16, 2023, the company received full payment for the shares issued.

As of December 31, 2024, the company’s liquidity ratio stood at 7.79 times, a decrease from 2023. This was due to the company’s repayment of construction debt for the Theeraporn Hospital and the current liabilities related to the construction creditors of Theeraporn Hospital. As a result, the ratio decreased compared to 2023, but the liquidity ratio remains at a healthy level.

Additionally, when considering the cash cycle from 2022 to 2024, the company had a cash cycle of (39) days, (50) days, and (91) days, respectively. The following is a breakdown of the average collection period, average sales period, and average payment period:

From 2022 to 2024, the company had an average collection period of approximately 0 to 2 days, as most of the customers pay for services upfront before receiving them. This results in the company having a small amount of trade receivables. The company’s average sales period from 2022 to 2024 was 3 days, 4 days, and 5 days, respectively. Furthermore, the company’s average payment period from 2022 to 2024 was 42 days, 55 days, and 96 days, respectively. As of December 31, 2024, the company’s cash cycle was (91) days. These ratios indicate that the company has good liquidity and is effective in managing its working capital.

Profitability Ratios

The company has a gross profit margin for the years 2022-2024 of 55.43%, 54.87%, and 52.70%, respectively. The decrease in gross profit margin from 2022 to 2023 was due to a reduction in service revenue, caused by the economic situation and an increase in competitors within the beauty service industry. For the year ending December 31, 2024, the company saw a decline in service revenue, and service costs also decreased in the same direction, resulting in a reduction in the gross profit margin compared to 2023.

The company has a net profit margin for the years 2022-2024 of 31.64%, 27.01%, and 25.12%, respectively. The continuous decrease in net profit margin follows the same trend as the gross profit margin. However, the net profit margin for the year ending December 31, 2024, decreased due to a decline in service revenue.


The company has a return on equity (ROE) for the years 2022-2024 of 58.23%, 17.07%, and 8.18%, respectively. In 2022, the ROE increased due to a rise in net profit to 270.27 million baht, and there was no increase in registered capital. The shareholders' equity increased from retained earnings but at a slower pace than net profit, resulting in a higher ROE. For the year ending December 31, 2023, the ROE decreased to 17.07%, down from 2022, due to a reduction in net profit, though shareholders' equity increased with an additional 1,332.84 million baht in capital surplus. This was because the company raised its registered capital by 45 million baht, from 130 million baht to 175 million baht. Between October 10-12, 2023, the company conducted an Initial Public Offering (IPO), offering 90 million new shares at 14 baht per share, with a total value of 1,260 million baht. The company received full payment for these shares on October 16, 2023. For the year ending December 31, 2024, the ROE decreased to 8.18%, down from 2023, due to a decline in net profit, although shareholders' equity continued to increase.

Operational Efficiency Ratios

As of December 31, 2022 – December 31, 2024, the company has a return on assets (ROA) of 53.78%, 18.89%, and 9.25%, respectively. In 2022, the company’s return on assets increased from 2021 due to a rise in net profit, as well as an increase in assets from the purchase of new land for the construction of a new hospital. However, the asset growth was at a slower rate than net profit. In 2023, the company’s return on assets decreased from 2022 due to a decline in net profit and an increase in assets from the Initial Public Offering (IPO) of 90 million new shares with a par value of 0.50 baht per share, offered at 14 baht per share, raising a total of 1,260 million baht.

For the year ending December 31, 2024, the company’s return on assets decreased from 2023 due to a decline in net profit, with assets increasing from assets under installation due to the construction of the Teeraporn Hospital.


Monetary Policy Analysis Ratios

As of December 31, 2022 – 2023, and for the year ending December 31, 2024, the company has a debt-to-equity ratio of 0.41, 0.06, and 0.09, respectively. In 2022, the company's debt-to-equity ratio increased to 0.41 due to an increase in debt from borrowing funds from a financial institution for the purpose of purchasing land to build a new hospital. The company has a loan covenant requiring it to maintain a debt-to-equity ratio not exceeding 2.50 times, and based on the above ratios, the company was able to comply with this requirement. In 2023, the debt-to-equity ratio decreased due to an increase in registered capital by 45 million baht, from an initial registered capital of 130 million baht to 175 million baht. Between October 10-12, 2023, the company conducted an Initial Public Offering (IPO), offering 90 million new shares at a par value of 0.50 baht per share, at a price of 14 baht per share, raising a total of 1,260 million baht. The company received full payment for these shares on October 16, 2023. As of December 31, 2023, the company had a capital surplus of 1,332.84 million baht. For the year ending December 31, 2024, the debt-to-equity ratio increased due to higher debt from creditors for the construction of Teeraporn Hospital. Additionally, shareholders' equity decreased due to a reduction in net profit.

As of December 31, 2022 – 2023, and for the year ending December 31, 2024, the company has an interest coverage ratio of 117.48, 157.53, and 466.92, respectively. These ratios reflect the company's strong ability to meet interest payments. In 2022, the company took out a long-term loan from a financial institution in mid-year to purchase land for the construction of a new hospital, which resulted in higher interest expenses. In 2023, the interest coverage ratio increased because, in October 2023, the company fully repaid the long-term loan to the financial institution, which led to a decrease in interest payments.

For the year ending December 31, 2024, the company’s interest coverage ratio increased due to the remaining interest payments being solely for lease-related interest.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

No

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

Impact of IPO

At the Extraordinary General Meeting of Shareholders No. 1/2023 held on February 9, 2023, the Company had an issued and paid-up registered capital of Baht 130.00 million. It consists of 260.00 million ordinary shares. Par value 0.50 baht per share

After this IPO. The number of shares of the Company will increase from 260.00 million shares to 350.00 million shares. Par value of 0.50 Baht or an increase of 90.00 million shares 25.71% of paid-up capital after IPO. This will cause the ratio compared to the proportion of shareholders or the number of shares of the company to decrease in the future due to the increase in the number of shares used as the basis for calculation (Dilution Effect) such as earnings per share, return on equity, etc.

However, in the long term, the company expects to benefit from the public offering, as it plans to use the proceeds from the initial public offering to finance the construction of the new hospital. Repay loans and use them as working capital to support business expansion. In addition, its status as a publicly listed company will support the company's image. It also allows companies to access diversified and lower-cost financing. All of these factors will support the company's long-term growth in performance and profitability. This is expected to offset the impact of the increase in shares.

Impact of building a new hospital

The company plans to change from a general medicine clinic to a small general hospital by building a new hospital on Somdet King Taksin Road. Samre Thonburi Bangkok. The project is expected to be completed in Q2/2025. The construction of the new hospital will allow the company to recognize increased sales and administrative expenses, such as furnishings and wages for new employees. however The company expects revenue growth and operating results to increase. This will offset the impact of the initial increase in costs.

Contents